| Dear Voornaam
Theres one month left to apply to take on one of cancers most complex questions. From establishing the mechanisms through which obesity and physical activity influence cancer risk to understanding how genetics, biology and social determinants affect outcomes in diverse populations our latest round of Cancer Grand Challenges addresses a broad spectrum of problems that, if solved, could transform the way we prevent, diagnose and treat cancer.
If youre ready to tackle one of our nine challenges with an international team, complete your eligibility questionnaire by 15 June and submit your expression of interest by 22 June for the chance to receive up to 20m in funding.
Put your questions to Tony Dickherber (the National Cancer Institute) and Laurence Dudley (Cancer Research UK) in a webinar at 45pm BST on 22 May and hear their insights and tips on the Cancer Grand Challenges application process.
Join us on Zoom:
https://nih.zoomgov.com/j/1616166539
Meeting ID: 161 616 6539
If dialling in, find your local number
|
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
REGISTER FOR THE MOLECULAR ANALYSIS FOR PRECISION ONCOLOGY CONGRESS 2023 MAP is back for another edition, on 46 October in Paris, and will offer the latest breaking data in the field of molecular profiling and personalised medicine.
Global experts in clinical and precision oncology, Charles Swanton (Cancer Research UK), John Haanen (ESMO) and Fabrice Andr (Unicancer), have put together a thought-provoking three-day agenda, delving into discoveries in cancer-stromal interactions, metastatic dissemination, drug response and resistance and much more.
Early-bird registration closes on 5 August so secure your place now. |
|
|---|
|
|---|
|
|
 GET YOUR GROUNDBREAKING RESEARCH OUT OF THE LAB WITH ONCOSTARS The Panacea OncoStars programme will inspire you to think about your cancer research from a patient impact perspective, help you understand the research translation ecosystem and support the commercial development of your bold and innovative vision. Whether you are starting with an idea or have a proof-of-concept, this programme is recommended at all stages.
The best companies will be offered a place in our more advanced programme, Develop AW23/24, which focuses on de-risking their startups, and they will compete for a non-dilutive prize worth 100k.
Apply by Sunday 21 May 2023 to unlock your commercial potential. |
|
|---|
|  AN INITIATIVE TO HELP YOUNG PEOPLE PROGRESS INTO STEM CAREERS AND RESEARCH Weve renewed our partnership with In2scienceUK to improve inclusion and diversity and inspire a new generation of researchers.
In2science supports young people from disadvantaged backgrounds into STEM subjects and careers.
The programme gives final year students practical experience, skills and confidence through placements and workshops.
|
|
|---|
|
|---|
|
|
DISCOVER WHATS NEXT IN RADIATION PROTECTION AT OUR RADIATION RESEARCH CONFERENCE Do you want to know more about the progress and future requirements in radiation protection?
Our dedicated event to radiation research will explore topics from Lynch syndrome patients to the effects of ultra-high dose rate beams, the challenges faced during the development of new nuclear builds in the UK and more.
Join us in Glasgow on 46 June to be part of our international conference, run in partnership with the Association for Radiation Research.
|
|
|---|
|
|---|
|
|
 DEVELOP YOUR EARLY-STAGE ONCOLOGY INNOVATION The Oncology Development Programme, run by Lean Life Sciences in partnership with Cancer Research Horizons and Innovate UK, will help you de-risk your oncology innovation and maximise your commercial and patient impact. Through a proven structured development programme, this opportunity applies business tools alongside one-to-one coaching and mentoring from senior industry and commercial experts-in-residence.
The accelerator is open to applications from UK organisations developing broad innovations in the field of oncology. Successful applicants will benefit from an intensive five-month programme, which will help them tell a compelling story to potential funders. |
|
|---|
|  DORA CELEBRATES 10 YEARS OF REFORMING RESEARCH ASSESSMENT The San Francisco Declaration on Research Assessment (aka DORA) is celebrating its 10-year anniversary this week. The global initiative works on improving the ways in which research outputs are assessed to ensure consistency, transparency and equity in research.
To mark the occasion, DORA is hosting a week of events to bring together the research community, reflect on progress and explore what lies ahead.
|
|
|---|
|
|---|
|
|
SHOWCASE YOUR WORK AT OUR CHILDRENS AND YOUNG PEOPLES CANCER RESEARCH CONFERENCE Are you working in childrens and young peoples cancer or interested in applying your research to this area?
Join your peers for our first conference dedicated to driving progress for childrens and young peoples cancer research. Richard Gilbertson, Anindita Roy, Anna Philpott, Tariq Enver and Isidro Corts-Ciriano are developing a thought-provoking and exciting agenda with opportunities for networking, scientific discussion and debate.
Submit an abstract to present your research, and if youre an early career researcher, youll also have the chance to give a proffered talk as part of our programme. |
|
|---|
|
|---|
|
|
| | | Online 10:00 AM 31 May 2023 |
|
|---|
|
|---|
| | | London, UK 2:30 PM 29 June 2023 |
|
|---|
|
|---|
| | | Cambridge, UK 05 July 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 05 July 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 27 September 2023 |
|
|---|
|
|---|
| | | Paris, France 04 October 2023 |
|
|---|
|
|---|
| | | London, UK 10 October 2023 |
|
|---|
|
|---|
| | | London, UK 14 November 2023 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
